{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:22:32Z","timestamp":1767903752622,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.annder.2021.12.002","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T12:29:39Z","timestamp":1643632179000},"page":"139-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Skin manifestations of hypereosinophilic syndrome are polymorphous and difficult to treat: A retrospective cohort study"],"prefix":"10.1016","volume":"149","author":[{"given":"G.","family":"Salomon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Severino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Casassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Bulai","family":"Livideanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lamant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2021.12.002_bib0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ajh.23293","article-title":"World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Gotlib","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annder.2021.12.002_bib0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2021.12.002_bib0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2021.12.002_bib0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.annder.2021.12.002_bib0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archderm.1978.01640160009003","article-title":"Dermatologic manifestations of the hypereosinophilic syndrome","volume":"114","author":"Kazmierowski","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2021.12.002_bib0100","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227137","article-title":"Idiopathic hypereosinophilic syndrome with cutaneous involvement: a comparative review of 32 cases","volume":"11","author":"Inayat","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.annder.2021.12.002_bib0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2230.1982.tb02426.x","article-title":"Skin lesions as the first manifestation of the hypereosinophilic syndrome","volume":"7","author":"Van den Hoogenband","year":"1982","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2021.12.002_bib0110","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2021.12.002_bib0115","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2021.12.002_bib0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-97-1-78","article-title":"NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations","volume":"97","author":"Fauci","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2021.12.002_bib0125","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ajh.25945","article-title":"Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: data from 151 patients","volume":"95","author":"Rohmer","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annder.2021.12.002_bib0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MD.0000000000000088","article-title":"The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype","volume":"93","author":"Lef\u00e8vre","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2021.12.002_bib0135","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/10428194.2012.731602","article-title":"Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients","volume":"54","author":"Helbig","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.annder.2021.12.002_bib0140","first-page":"881","article-title":"Clinical characteristics and long-term therapeutic effects of 60 patients with idiopathic hypereosinophilic syndrome in a single center","volume":"37","author":"Qu","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821001101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821001101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:52Z","timestamp":1758971452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963821001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0151963821001101"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2021.12.002","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin manifestations of hypereosinophilic syndrome are polymorphous and difficult to treat: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}